Net Income (Loss) Attributable to Parent in USD of Anixa Biosciences Inc from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Anixa Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q2 2025.
  • Anixa Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending 31 Jul 2025 was -$2.26M, a 31.1% increase year-over-year.
  • Anixa Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending 31 Jul 2025 was -$11.1M, a 10.1% increase year-over-year.
  • Anixa Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$12.6M, a 28% decline from 2023.
  • Anixa Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$9.81M, a 27.8% increase from 2022.
  • Anixa Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$13.6M, a 4.95% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Anixa Biosciences Inc Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$11.1M -$2.26M +$1.02M +31.1% 01 May 2025 31 Jul 2025 10-Q 10 Sep 2025
Q1 2025 -$12.1M -$2.79M +$349K +11.1% 01 Feb 2025 30 Apr 2025 10-Q 28 May 2025
Q4 2024 -$12.5M -$3.18M +$71K +2.18% 01 Nov 2024 31 Jan 2025 10-Q 11 Mar 2025
Q3 2024 -$12.6M -$2.88M -$193K -7.18% 01 Aug 2024 31 Oct 2024 10-K 10 Jan 2025
Q2 2024 -$12.4M -$3.28M -$766K -30.5% 01 May 2024 31 Jul 2024 10-Q 10 Sep 2025
Q1 2024 -$11.6M -$3.14M -$851K -37.2% 01 Feb 2024 30 Apr 2024 10-Q 28 May 2025
Q4 2023 -$10.7M -$3.26M -$933K -40.2% 01 Nov 2023 31 Jan 2024 10-Q 11 Mar 2025
Q3 2023 -$9.81M -$2.69M +$786K +22.6% 01 Aug 2023 31 Oct 2023 10-K 10 Jan 2025
Q2 2023 -$10.6M -$2.51M +$235K +8.56% 01 May 2023 31 Jul 2023 10-Q 06 Sep 2024
Q1 2023 -$10.8M -$2.29M +$1.26M +35.4% 01 Feb 2023 30 Apr 2023 10-Q 04 Jun 2024
Q4 2022 -$12.1M -$2.32M +$1.51M +39.4% 01 Nov 2022 31 Jan 2023 10-Q 12 Mar 2024
Q3 2022 -$13.6M -$3.48M +$537K +13.4% 01 Aug 2022 31 Oct 2022 10-K 16 Jan 2024
Q2 2022 -$14.1M -$2.75M +$1.59M +36.6% 01 May 2022 31 Jul 2022 10-Q 06 Sep 2023
Q1 2022 -$15.7M -$3.54M -$1.15M -47.7% 01 Feb 2022 30 Apr 2022 10-Q 14 Jun 2023
Q4 2021 -$14.6M -$3.83M -$1.62M -73.4% 01 Nov 2021 31 Jan 2022 10-Q 17 Mar 2023
Q3 2021 -$13M -$4.01M -$1.79M -80.4% 01 Aug 2021 31 Oct 2021 10-K 04 Jan 2023
Q2 2021 -$11.2M -$4.33M -$1.77M -69.2% 01 May 2021 31 Jul 2021 10-Q 09 Sep 2022
Q1 2021 -$9.39M -$2.4M +$241K +9.13% 01 Feb 2021 30 Apr 2021 10-Q 10 Jun 2022
Q4 2020 -$9.63M -$2.21M +$385K +14.8% 01 Nov 2020 31 Jan 2021 10-Q 11 Mar 2022
Q3 2020 -$10M -$2.22M 01 Aug 2020 31 Oct 2020 10-K 04 Jan 2022
Q2 2020 -$2.56M -$422K -19.7% 01 May 2020 31 Jul 2020 10-Q 01 Sep 2021
Q1 2020 -$2.64M 01 Feb 2020 30 Apr 2020 10-Q 10 Jun 2021
Q4 2019 -$2.59M 01 Nov 2019 31 Jan 2020 10-Q 11 Mar 2021
Q2 2019 -$2.14M +$3.34M +60.9% 01 May 2019 31 Jul 2019 10-Q 08 Sep 2020
Q3 2018 -$14M -$5.3M -$5.53M -2478% 01 Aug 2018 31 Oct 2018 10-K 11 Jan 2019
Q2 2018 -$8.47M -$5.48M -$3.68M -205% 01 May 2018 31 Jul 2018 10-Q 07 Sep 2018
Q1 2018 -$4.79M -$1.38M -$1.54M -959% 01 Feb 2018 30 Apr 2018 10-Q 11 Jun 2018
Q4 2017 -$3.25M -$1.84M +$1.76M +48.9% 01 Nov 2017 31 Jan 2018 10-Q 09 Mar 2018
Q3 2017 -$5.01M $223K +$1.27M 01 Aug 2017 31 Oct 2017 10-K 11 Jan 2019
Q2 2017 -$6.28M -$1.79M -$691K -62.6% 01 May 2017 31 Jul 2017 10-Q 07 Sep 2018
Q1 2017 -$5.59M $160K +$1.43M 01 Feb 2017 30 Apr 2017 10-Q 11 Jun 2018
Q4 2016 -$7.02M -$3.6M -$2M -126% 01 Nov 2016 31 Jan 2017 10-Q 09 Mar 2018
Q3 2016 -$5.02M -$1.05M +$245K +18.9% 01 Aug 2016 31 Oct 2016 10-K 09 Jan 2018
Q2 2016 -$5.26M -$1.1M +$498K +31.1% 01 May 2016 31 Jul 2016 10-Q 08 Sep 2017
Q1 2016 -$5.76M -$1.27M +$965K +43.1% 01 Feb 2016 30 Apr 2016 10-Q 26 May 2017
Q4 2015 -$6.72M -$1.59M -$5.35M -142% 01 Nov 2015 31 Jan 2016 10-Q 16 Mar 2017
Q3 2015 -$1.38M -$1.29M +$1.86M +59% 01 Aug 2015 31 Oct 2015 10-K 08 Dec 2016
Q2 2015 -$3.24M -$1.6M -$2.01M -490% 01 May 2015 31 Jul 2015 10-Q 19 Aug 2016
Q1 2015 -$1.23M -$2.24M +$1.01M +31.2% 01 Feb 2015 30 Apr 2015 10-Q 20 May 2016
Q4 2014 -$2.24M $3.75M +$7.37M 01 Nov 2014 31 Jan 2015 10-Q 19 Feb 2016
Q3 2014 -$9.61M -$3.15M -$227K -7.75% 01 Aug 2014 31 Oct 2014 10-K 23 Dec 2015
Q2 2014 -$9.38M $411K +$2.99M 01 May 2014 31 Jul 2014 10-Q 18 Aug 2015
Q1 2014 -$12.4M -$3.25M -$773K -31.2% 01 Feb 2014 30 Apr 2014 10-Q 22 May 2015
Q4 2013 -$11.6M -$3.61M -$1.52M -72.5% 01 Nov 2013 31 Jan 2014 10-Q 09 Mar 2015
Q3 2013 -$10.1M -$2.93M -$1.07M -57.3% 01 Aug 2013 31 Oct 2013 10-K 29 Jan 2015
Q2 2013 -$9.01M -$2.58M -$1.95M -310% 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014
Q1 2013 -$7.06M -$2.48M -$1.6M -182% 01 Feb 2013 30 Apr 2013 10-Q 16 Jun 2014
Q4 2012 -$5.46M -$2.09M -$1.21M -136% 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014
Q3 2012 -$4.25M -$1.86M +$931K +33.3% 01 Aug 2012 31 Oct 2012 10-K 29 Jan 2013
Q2 2012 -$5.18M -$629K +$1.14M +64.5% 01 May 2012 31 Jul 2012 10-Q/A 20 Sep 2013
Q1 2012 -$6.33M -$877K +$410K +31.9% 01 Feb 2012 30 Apr 2012 10-Q/A 19 Jun 2013
Q4 2011 -$6.74M -$886K +$640K +41.9% 01 Nov 2011 31 Jan 2012 10-Q/A 25 Mar 2013
Q3 2011 -$7.38M -$2.79M 01 Aug 2011 31 Oct 2011 10-K 29 Jan 2013
Q2 2011 -$1.77M -$503K -39.6% 01 May 2011 31 Jul 2011 10-K 29 Jan 2013
Q1 2011 -$1.29M 01 Feb 2011 30 Apr 2011 10-K 29 Jan 2013
Q4 2010 -$1.53M 01 Nov 2010 31 Jan 2011 10-K 29 Jan 2013
Q2 2010 -$1.27M 01 May 2010 31 Jul 2010 10-Q/A 14 Oct 2011

Anixa Biosciences Inc Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$12.6M -$2.74M -28% 01 Nov 2023 31 Oct 2024 10-K 10 Jan 2025
2023 -$9.81M +$3.78M +27.8% 01 Nov 2022 31 Oct 2023 10-K 10 Jan 2025
2022 -$13.6M -$641K -4.95% 01 Nov 2021 31 Oct 2022 10-K 16 Jan 2024
2021 -$13M -$2.94M -29.3% 01 Nov 2020 31 Oct 2021 10-K 04 Jan 2023
2020 -$10M +$1.63M +14% 01 Nov 2019 31 Oct 2020 10-K 04 Jan 2022
2019 -$11.6M +$2.35M +16.8% 01 Nov 2018 31 Oct 2019 10-K 07 Jan 2021
2018 -$14M -$8.99M -179% 01 Nov 2017 31 Oct 2018 10-K 11 Jan 2019
2017 -$5.01M +$7.44K +0.15% 01 Nov 2016 31 Oct 2017 10-K 11 Jan 2019
2016 -$5.02M -$3.64M -264% 01 Nov 2015 31 Oct 2016 10-K 09 Jan 2018
2015 -$1.38M +$8.23M +85.6% 01 Nov 2014 31 Oct 2015 10-K 08 Dec 2016
2014 -$9.61M +$474K +4.7% 01 Nov 2013 31 Oct 2014 10-K 23 Dec 2015
2013 -$10.1M -$5.83M -137% 01 Nov 2012 31 Oct 2013 10-K 29 Jan 2015
2012 -$4.25M +$3.13M +42.4% 01 Nov 2011 31 Oct 2012 10-K/A 17 Jan 2014
2011 -$7.38M -$2.2M -42.6% 01 Nov 2010 31 Oct 2011 10-K 29 Jan 2013
2010 -$5.18M 01 Nov 2009 31 Oct 2010 10-K 30 Jan 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.